• We have defined work flows to assess and select solid forms in a cost and time efficient manner that meets the needs of each individual program.

  • We understand stakeholder needs and match them to the widest array of drug delivery solutions to give your therapy the best potential for success on the path from Phase II through scale-up and commercial supply.

  • We can assist in the development of necessary validation documents, including test protocols, based on current industry thinking and alignment with global regulatory authority expectations.

  • Our cell therapy product characterization services combine rapid PCR, ELISA and custom methods tailored to these product types from a single contract partner with fully compliant cGMP facilities and options for research grade testing available.

  • Biocatalysis enables cost efficient and environmentally friendly manufacturing through enzymatic synthesis and provides pure -regio, chemo- and enantioselective compounds when compared to traditional chemical synthesis.